Phase 1 study in healthy volunteers of the o-glcnacase inhibitor asn120290 as a novel therapy for progressive supranuclear palsy and related tauopathiesJ. Michael Ryan,Anna Quattropani,Khalid Abd-Elaziz,Izaak den Daas,Manfred Schneider,Solenne Ousson,Maud Neny,Astrid Sand,Jennifer Hantson,Bruno Permanne,Christoph Wiessner,Dirk BeherAlzheimers & Dementia（2018）引用 17|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
